An immunocytochemistry detection kit based on proprietary E7 antibody technology for detecting cervical intraepithelial lesion samples. The kit utilizes E7 antibody labeling to identify and distinguish cervical epithelial cell samples.
Manufactured by
Attogen Biomedical(Suzhou)Ltd.Inc
China
Attogen Biomedical (Suzhou) Ltd. is a National High-tech Enterprise focused on women's health diagnostics. The company developed China's first cervical cancer-specific protein biomarker detection kits, AI-powered automated medical detection equipment, and related diagnostic software. Founded by Dr. Chang Xiaojia, trained under Nobel laureates at Rockefeller University. ISO13485 certified with over 30 patents.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GUANGZHOU BIOTRON TECHNOLOGY CO., LTD.
China · 1 relevant product
Shenzhen Uni-medica Technology Co., Ltd
China · 2 relevant products
Xiamen Talent Biomedical Technology Co.,Ltd.
China · 2 relevant products
50 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 18 relevant matches
GUANGZHOU BIOTRON TECHNOLOGY CO., LTD. · China
A fluorescent PCR melting curve method-based detection kit for genotyping Human Papillomavirus through E6/E7 mRNA analysis. This kit enables molecular diagnostics of HPV infections at the mRNA level.
Shenzhen Uni-medica Technology Co., Ltd · China
A diagnostic kit for qualitative detection of 15 high-risk HPV E6/E7 mRNA types (16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) in cervical exfoliated cell samples. The kit detects HPV at the viral gene transcription level, directly reflecting the expression of HR-HPV E6/E7 oncogenic genes, and is closely associated with viral integration and cellular malignant transformation. It can serve as a risk assessment tool for cervical cancer and precancerous lesions, providing accurate information for cervical cancer screening and disease prediction.
guangzhou biotron technolongy co.,ltd · China
An HPV E6/E7 mRNA genotyping detection assay that provides risk stratification for cervical lesions. It reduces unnecessary colposcopy referrals while improving the detection rate of CIN2+ lesions and enabling more precise clinical management.
15 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products